Health Compugen’s COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Anti-Tumor Activity and Immune Activation in Platinum Resistant Ovarian Cancer Patients December 1, 2022
Health Evoke Pharma Strengthens its Intellectual Property Portfolio with a Notice of Allowance from the USPTO for a Patent Application Related to GIMOTI® December 1, 2022
Health Kintara Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement December 1, 2022
Health Regeneron ESMO IO Presentations Highlight Potential of Fianlimab and Libtayo® (cemiplimab) in Multiple Solid Tumor Types December 1, 2022
Health Tonix Pharmaceuticals Presents Development Update on Potential Smallpox and Monkeypox Vaccine TNX-801 in an Oral Presentation at the World Vaccine and Immunotherapy Congress December 1, 2022
Health ELEVEN EXPERTS FROM LEADING MEDICAL INSTITUTIONS AND EIGHT EXPERTS FROM EISAI* PUBLISH FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER’S DISEASE IN THE NEW ENGLAND JOURNAL OF MEDICINE November 30, 2022
Health Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference November 30, 2022
Health Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development November 30, 2022
Search
Health
December 1, 2022
December 1, 2022
December 1, 2022
December 1, 2022
December 1, 2022
December 1, 2022
November 30, 2022
November 30, 2022
November 30, 2022
November 30, 2022
